Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Truist Securities Maintains Buy on PACS Group, Lowers Price Target to $32

Author: Benzinga Newsdesk | January 06, 2025 08:56am
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and lowers the price target from $46 to $32.

Posted In: PACS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist